Table of Contents Executive Summary 1 Industry Overview of Essential Thrombocythemia Drug 1.1 Definition of Essential Thrombocythemia Drug 1.2 Essential Thrombocythemia Drug Segment by Type 1.2.1 Global Essential Thrombocythemia Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Givinostat 1.2.3 Idasanutlin 1.2.4 Pracinostat 1.2.5 Ruxolitinib Phosphate 1.2.6 Others 1.3 Essential Thrombocythemia Drug Segment by Applications 1.3.1 Global Essential Thrombocythemia Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Research Center 1.3.3 Hospital 1.3.4 Clinic 1.3.5 Others 1.4 Global Essential Thrombocythemia Drug Overall Market 1.4.1 Global Essential Thrombocythemia Drug Revenue (2014-2025) 1.4.2 Global Essential Thrombocythemia Drug Production (2014-2025) 1.4.3 North America Essential Thrombocythemia Drug Status and Prospect (2014-2025) 1.4.4 Europe Essential Thrombocythemia Drug Status and Prospect (2014-2025) 1.4.5 China Essential Thrombocythemia Drug Status and Prospect (2014-2025) 1.4.6 Japan Essential Thrombocythemia Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Essential Thrombocythemia Drug Status and Prospect (2014-2025) 1.4.8 India Essential Thrombocythemia Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Essential Thrombocythemia Drug 2.3 Manufacturing Process Analysis of Essential Thrombocythemia Drug 2.4 Industry Chain Structure of Essential Thrombocythemia Drug 3 Development and Manufacturing Plants Analysis of Essential Thrombocythemia Drug 3.1 Capacity and Commercial Production Date 3.2 Global Essential Thrombocythemia Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Essential Thrombocythemia Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Essential Thrombocythemia Drug Production and Capacity Analysis 4.2 Essential Thrombocythemia Drug Revenue Analysis 4.3 Essential Thrombocythemia Drug Price Analysis 4.4 Market Concentration Degree 5 Essential Thrombocythemia Drug Regional Market Analysis 5.1 Essential Thrombocythemia Drug Production by Regions 5.1.1 Global Essential Thrombocythemia Drug Production by Regions 5.1.2 Global Essential Thrombocythemia Drug Revenue by Regions 5.2 Essential Thrombocythemia Drug Consumption by Regions 5.3 North America Essential Thrombocythemia Drug Market Analysis 5.3.1 North America Essential Thrombocythemia Drug Production 5.3.2 North America Essential Thrombocythemia Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Essential Thrombocythemia Drug Import and Export 5.4 Europe Essential Thrombocythemia Drug Market Analysis 5.4.1 Europe Essential Thrombocythemia Drug Production 5.4.2 Europe Essential Thrombocythemia Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Essential Thrombocythemia Drug Import and Export 5.5 China Essential Thrombocythemia Drug Market Analysis 5.5.1 China Essential Thrombocythemia Drug Production 5.5.2 China Essential Thrombocythemia Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Essential Thrombocythemia Drug Import and Export 5.6 Japan Essential Thrombocythemia Drug Market Analysis 5.6.1 Japan Essential Thrombocythemia Drug Production 5.6.2 Japan Essential Thrombocythemia Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Essential Thrombocythemia Drug Import and Export 5.7 Southeast Asia Essential Thrombocythemia Drug Market Analysis 5.7.1 Southeast Asia Essential Thrombocythemia Drug Production 5.7.2 Southeast Asia Essential Thrombocythemia Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Essential Thrombocythemia Drug Import and Export 5.8 India Essential Thrombocythemia Drug Market Analysis 5.8.1 India Essential Thrombocythemia Drug Production 5.8.2 India Essential Thrombocythemia Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Essential Thrombocythemia Drug Import and Export 6 Essential Thrombocythemia Drug Segment Market Analysis (by Type) 6.1 Global Essential Thrombocythemia Drug Production by Type 6.2 Global Essential Thrombocythemia Drug Revenue by Type 6.3 Essential Thrombocythemia Drug Price by Type 7 Essential Thrombocythemia Drug Segment Market Analysis (by Application) 7.1 Global Essential Thrombocythemia Drug Consumption by Application 7.2 Global Essential Thrombocythemia Drug Consumption Market Share by Application (2014-2019) 8 Essential Thrombocythemia Drug Major Manufacturers Analysis 8.1 AbbVie Inc 8.1.1 AbbVie Inc Essential Thrombocythemia Drug Production Sites and Area Served 8.1.2 AbbVie Inc Product Introduction, Application and Specification 8.1.3 AbbVie Inc Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Aop Orphan Pharmaceuticals AG 8.2.1 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Production Sites and Area Served 8.2.2 Aop Orphan Pharmaceuticals AG Product Introduction, Application and Specification 8.2.3 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 F. Hoffmann-La Roche Ltd 8.3.1 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Production Sites and Area Served 8.3.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification 8.3.3 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Galena Biopharma Inc 8.4.1 Galena Biopharma Inc Essential Thrombocythemia Drug Production Sites and Area Served 8.4.2 Galena Biopharma Inc Product Introduction, Application and Specification 8.4.3 Galena Biopharma Inc Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Incyte Corp 8.5.1 Incyte Corp Essential Thrombocythemia Drug Production Sites and Area Served 8.5.2 Incyte Corp Product Introduction, Application and Specification 8.5.3 Incyte Corp Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Italfarmaco SpA 8.6.1 Italfarmaco SpA Essential Thrombocythemia Drug Production Sites and Area Served 8.6.2 Italfarmaco SpA Product Introduction, Application and Specification 8.6.3 Italfarmaco SpA Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 MEI Pharma Inc 8.7.1 MEI Pharma Inc Essential Thrombocythemia Drug Production Sites and Area Served 8.7.2 MEI Pharma Inc Product Introduction, Application and Specification 8.7.3 MEI Pharma Inc Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 PharmaEssentia Corp 8.8.1 PharmaEssentia Corp Essential Thrombocythemia Drug Production Sites and Area Served 8.8.2 PharmaEssentia Corp Product Introduction, Application and Specification 8.8.3 PharmaEssentia Corp Essential Thrombocythemia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 9 Development Trend of Analysis of Essential Thrombocythemia Drug Market 9.1 Global Essential Thrombocythemia Drug Market Trend Analysis 9.1.1 Global Essential Thrombocythemia Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Essential Thrombocythemia Drug Regional Market Trend 9.2.1 North America Essential Thrombocythemia Drug Forecast 2019-2025 9.2.2 Europe Essential Thrombocythemia Drug Forecast 2019-2025 9.2.3 China Essential Thrombocythemia Drug Forecast 2019-2025 9.2.4 Japan Essential Thrombocythemia Drug Forecast 2019-2025 9.2.5 Southeast Asia Essential Thrombocythemia Drug Forecast 2019-2025 9.2.6 India Essential Thrombocythemia Drug Forecast 2019-2025 9.3 Essential Thrombocythemia Drug Market Trend (Product Type) 9.4 Essential Thrombocythemia Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Essential Thrombocythemia Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Essential Thrombocythemia Drug Table Global Essential Thrombocythemia Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Essential Thrombocythemia Drug Production Market Share by Types in 2018 Figure Givinostat Product Picture Figure Idasanutlin Product Picture Figure Pracinostat Product Picture Figure Ruxolitinib Phosphate Product Picture Figure Others Product Picture Table Global Essential Thrombocythemia Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Essential Thrombocythemia Drug Consumption Market Share by Applications in 2018 Figure Research Center Figure Hospital Figure Clinic Figure Others Figure Global Essential Thrombocythemia Drug Revenue (Million USD) (2014-2025) Figure Global Essential Thrombocythemia Drug Production (K Pcs) (2014-2025) Figure North America Essential Thrombocythemia Drug Market Size (Million USD) (2014-2025) Figure Europe Essential Thrombocythemia Drug Market Size (Million USD) (2014-2025) Figure China Essential Thrombocythemia Drug Market Size (Million USD) (2014-2025) Figure Japan Essential Thrombocythemia Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Essential Thrombocythemia Drug Market Size (Million USD) (2014-2025) Figure India Essential Thrombocythemia Drug Market Size (Million USD) (2014-2025) Table Essential Thrombocythemia Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Essential Thrombocythemia Drug in 2018 Figure Manufacturing Process Analysis of Essential Thrombocythemia Drug Figure Industry Chain Structure of Essential Thrombocythemia Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Essential Thrombocythemia Drug Manufacturing Plants Distribution Table Essential Thrombocythemia Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Essential Thrombocythemia Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Essential Thrombocythemia Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Essential Thrombocythemia Drug Production Market Share of Major Manufacturers (2014-2019) Figure Essential Thrombocythemia Drug Production Share by Manufacturers in 2018 Table Essential Thrombocythemia Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Essential Thrombocythemia Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Essential Thrombocythemia Drug Revenue Share by Manufacturers in 2018 Table Essential Thrombocythemia Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Essential Thrombocythemia Drug Production by Regions 2014-2019 (K Pcs) Table Global Essential Thrombocythemia Drug Production Market Share by Regions 2014-2019 Figure Global Essential Thrombocythemia Drug Production Market Share by Regions in 2018 Table Global Essential Thrombocythemia Drug Revenue by Regions 2014-2019 (Million USD) Table Global Essential Thrombocythemia Drug Revenue Market Share by Regions 2014-2019 Figure Global Essential Thrombocythemia Drug Revenue Market Share by Regions in 2018 Table Global Essential Thrombocythemia Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Essential Thrombocythemia Drug Consumption Market Share by Regions 2014-2019 Figure North America Essential Thrombocythemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Essential Thrombocythemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Essential Thrombocythemia Drug Production, Consumption Import and Export (K Pcs) Figure Europe Essential Thrombocythemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Essential Thrombocythemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Essential Thrombocythemia Drug Production, Consumption Import and Export (K Pcs) Figure China Essential Thrombocythemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Essential Thrombocythemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Essential Thrombocythemia Drug Production, Consumption Import and Export (K Pcs) Figure Japan Essential Thrombocythemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Essential Thrombocythemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Essential Thrombocythemia Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Essential Thrombocythemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Essential Thrombocythemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Essential Thrombocythemia Drug Production, Consumption Import and Export (K Pcs) Figure India Essential Thrombocythemia Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Essential Thrombocythemia Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Essential Thrombocythemia Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Essential Thrombocythemia Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Essential Thrombocythemia Drug Market Share by Application (2014-2019) Table AbbVie Inc Essential Thrombocythemia Drug Production Sites and Area Served Table AbbVie Inc Essential Thrombocythemia Drug Product Introduction, Application and Specification Table AbbVie Inc Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table AbbVie Inc Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table AbbVie Inc Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure AbbVie Inc Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table AbbVie Inc Essential Thrombocythemia Drug Main Business and Markets Served Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Production Sites and Area Served Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Product Introduction, Application and Specification Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Main Business and Markets Served Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Production Sites and Area Served Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Product Introduction, Application and Specification Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Main Business and Markets Served Table Galena Biopharma Inc Essential Thrombocythemia Drug Production Sites and Area Served Table Galena Biopharma Inc Essential Thrombocythemia Drug Product Introduction, Application and Specification Table Galena Biopharma Inc Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Galena Biopharma Inc Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table Galena Biopharma Inc Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure Galena Biopharma Inc Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table Galena Biopharma Inc Essential Thrombocythemia Drug Main Business and Markets Served Table Incyte Corp Essential Thrombocythemia Drug Production Sites and Area Served Table Incyte Corp Essential Thrombocythemia Drug Product Introduction, Application and Specification Table Incyte Corp Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Incyte Corp Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table Incyte Corp Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure Incyte Corp Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table Incyte Corp Essential Thrombocythemia Drug Main Business and Markets Served Table Italfarmaco SpA Essential Thrombocythemia Drug Production Sites and Area Served Table Italfarmaco SpA Essential Thrombocythemia Drug Product Introduction, Application and Specification Table Italfarmaco SpA Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Italfarmaco SpA Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table Italfarmaco SpA Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure Italfarmaco SpA Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table Italfarmaco SpA Essential Thrombocythemia Drug Main Business and Markets Served Table MEI Pharma Inc Essential Thrombocythemia Drug Production Sites and Area Served Table MEI Pharma Inc Essential Thrombocythemia Drug Product Introduction, Application and Specification Table MEI Pharma Inc Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table MEI Pharma Inc Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table MEI Pharma Inc Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure MEI Pharma Inc Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table MEI Pharma Inc Essential Thrombocythemia Drug Main Business and Markets Served Table PharmaEssentia Corp Essential Thrombocythemia Drug Production Sites and Area Served Table PharmaEssentia Corp Essential Thrombocythemia Drug Product Introduction, Application and Specification Table PharmaEssentia Corp Essential Thrombocythemia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table PharmaEssentia Corp Essential Thrombocythemia Drug Production Growth Rate (2014-2019) Table PharmaEssentia Corp Essential Thrombocythemia Drug Production Market Share (2014-2019) Figure PharmaEssentia Corp Essential Thrombocythemia Drug Revenue Market Share (2014-2019) Table PharmaEssentia Corp Essential Thrombocythemia Drug Main Business and Markets Served Figure Global Essential Thrombocythemia Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Essential Thrombocythemia Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Essential Thrombocythemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Essential Thrombocythemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Essential Thrombocythemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Essential Thrombocythemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Essential Thrombocythemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Essential Thrombocythemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Essential Thrombocythemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Essential Thrombocythemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Essential Thrombocythemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Essential Thrombocythemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Essential Thrombocythemia Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Essential Thrombocythemia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Essential Thrombocythemia Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Essential Thrombocythemia Drug by Application (2019-2025) Table Essential Thrombocythemia Drug Distributors List Table Essential Thrombocythemia Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AbbVie Inc Aop Orphan Pharmaceuticals AG F. Hoffmann-La Roche Ltd Galena Biopharma Inc Incyte Corp Italfarmaco SpA MEI Pharma Inc PharmaEssentia Corp